Department of Gastroenterology and Hematology started when Dr. Tsuda was named as the first professor in 1975. Since then, we’ve strengthened our commitment to provide medical care of the highest quality for gastroenterological disorders, hepatic disorders, hematological disorders, and a variety of malignant neoplasms. In addition, we are currently involved in many clinical trials and the development of new therapies including newly available targeted therapeutics.
Our educational programs include teaching activities in undergraduate medical education, graduate school, residency programs, and subspecialty fellowship training. Our residency program aims to train residents as general physicians well-prepared for any career path within internal medicine. The goal of our subspecialty training program is to produce high-caliber individuals in each field we cover.
We have the following research groups.
- Hematology / Oncology
- Digestive system cancer
Gastrointestinal cancers are treated with non-surgical treatment such as endocopic therapy and chemotherapy.
- Inflammatory bowel disease (IBD)
We provide patients current treatments for IBD, including medications, lifestyle modifications and surgery if necessary.
- Viral hepatitis
We offer state-of-the-art antiviral therapy for hepatitis B and C. Endoscopic treatment are performed for variceal bleeding caused by cirrhosis.
- Liver cancer
Non-surgical therapy such as radiofrequency ablation provides minimally invasive treatments for patients extend life and improve quality of life.
- Malignant hematological disorders
For malignant diseases, such as leukemia, lymphoma, myeloma, and myelodysplastic syndrome (MDS), we provide the best treatment based on current knowledge about effective treatments.
- Non-malignant hematologic disorders
Treatment of benign blood disorders such as anemia and hemorrhagic diseases varies with the cause.
- Population-based cohort study on malignant disorders
- Nationwide survey to characterize Japanese patients with myelofibrosis
- Epidemiology of Human T-cell lymphotrophic virus (HTLV)-1 related diseases
- Nutritional management for patients with liver cirrhosis
- Construction of follow up system for HCV positive residents in local municipality
- Evaluation of liver fibrosis using transient elastography
- Understanding natural course of inflammatory bowel disease
- Molecular and cellular pathogenesis of Myeloproliferative neoplasms (MPN)
- Developing novel targeted therapy for MPN
- Molecular mechanisms of Adult T-cell leukemia-lymphoma leukemogenesis
- Development of novel therapeutic method for inflammatory bowel diseases using mesenchymal stem cells
University of Miyazaki
5200 Kiyotakecho Kihara, Miyazaki 889-1692, Japan
For career opportunities, please contact:
Dr. S Yamamoto, MD.